Striving to make the incurable,curable

Immetacyte, leading the T-Cell therapy revolution

Our Solution

We're developing this truly personalised TIL therapy in a range of cancer indications, by improving and streamlining the process.

Read More

About Us

We're a clinical-stage immuno-oncology company with an established, profitable GMP CDMO business for advanced cell therapies.

Read More

News & Events

All the very latest developments from our team.

Read More